How much funding has Carrick Therapeutics raised?

Carrick Therapeutics has raised $155.0M in total funding, most recently a Series C round.

Who are Carrick Therapeutics's investors?

Carrick Therapeutics's investors include Pfizer Ventures, GV, B Capital Group, ARCH Venture Partners, Rosetta Capital, Revelation Biosciences.

When was Carrick Therapeutics founded?

Carrick Therapeutics was founded in 2016.

Where is Carrick Therapeutics headquartered?

Carrick Therapeutics is headquartered in Dublin, Massachusetts, Ireland.

What industry is Carrick Therapeutics in?

Carrick Therapeutics operates in Biotech, Healthcare.

How many employees does Carrick Therapeutics have?

Carrick Therapeutics has 1-10 employees.

Carrick Therapeutics

Carrick Therapeutics, Inc.

Dublin, Ireland · Founded 2016 · $155.0M raised

Biotech

Healthcare

Headquarters: Dublin, Massachusetts
Employees: 1–10
Founded: 2016
Business Model: B2B

Website: carricktherapeutics.com
Total Funding: $155.0M
Last Round: $25.0M Series CDec 2022
Rounds: 5

About

Carrick Therapeutics is a clinical-stage biopharmaceutical company focused on building novel oncology therapies for patients with aggressive and resistant cancers including breast, prostate, ovarian, pancreatic, and Ewing's sarcoma. The company translates in-house and in-licensed assets through a network of pharma partners, clinicians, and research institutions. Corporate headquarters is in Boston, Massachusetts.

Summary

Carrick Therapeutics is a Biotech company based in Dublin, Ireland, founded in 2016. It has raised $155.0M in total across 5 rounds, most recently a $25.0M Series C round in Dec 2022. Investors include Pfizer Ventures, GV and B Capital Group.